Teri Loxam
CIK: 0001829111
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (21 total)
- Jun 15, 2026PCVX
Vaxcyte, Inc.
Award(A)Direct2.3K shares- - Mar 26, 2026CMPS
COMPASS Pathways plc
Award(A)Direct75K shares- - Mar 11, 2026CMPS
COMPASS Pathways plc
Tax Payment(F)Direct1.8K shares at avg. $6.89$12K - Mar 2, 2026CMPS
COMPASS Pathways plc
Tax Payment(F)Direct4.5K shares at avg. $7.02$31K - Jun 12, 2025PCVX
Vaxcyte, Inc.
Award(A)Direct3K shares- - Mar 11, 2025CMPS
COMPASS Pathways plc
Award(A)Direct25K shares- - Mar 3, 2025CMPS
COMPASS Pathways plc
Tax Payment(F)Direct4.5K shares at avg. $3.67$16K - Jan 15, 2025PCVX
Vaxcyte, Inc.
Sale(S)Direct529 shares at avg. $88.54$47K - Jan 15, 2025PCVX
Vaxcyte, Inc.
Sale(S)Direct1.1K shares at avg. $82.89$94K - Jan 15, 2025PCVX
Vaxcyte, Inc.
Sale(S)Direct1.2K shares at avg. $83.93$101K - Jan 15, 2025PCVX
Vaxcyte, Inc.
Sale(S)Direct1K shares at avg. $85.29$89K - Jan 15, 2025PCVX
Vaxcyte, Inc.
Sale(S)Direct966 shares at avg. $86.26$83K - Jan 15, 2025PCVX
Vaxcyte, Inc.
Sale(S)Direct1K shares at avg. $87.38$89K - Jan 15, 2025PCVX
Vaxcyte, Inc.
Exercise(M)Direct6.3K shares at avg. $22.70$142K - Jan 15, 2025PCVX
Vaxcyte, Inc.
Sale(S)Direct146 shares at avg. $80.46$12K - Jan 15, 2025PCVX
Vaxcyte, Inc.
Sale(S)Direct215 shares at avg. $81.53$18K - Sep 17, 2024PCVX
Vaxcyte, Inc.
Sale(S)Direct241 shares at avg. $114.64$28K - Sep 17, 2024PCVX
Vaxcyte, Inc.
Sale(S)Direct1.4K shares at avg. $115.32$167K - Sep 17, 2024PCVX
Vaxcyte, Inc.
Sale(S)Direct4.3K shares at avg. $116.62$502K - Sep 17, 2024PCVX
Vaxcyte, Inc.
Sale(S)Direct256 shares at avg. $117.51$30K - Sep 17, 2024PCVX
Vaxcyte, Inc.
Exercise(M)Direct6.3K shares at avg. $22.70$142K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 15, 2026 | PCVX Vaxcyte, Inc. | Award(A) | 2,265 | - | $0 | Direct |
| Mar 26, 2026 | CMPS COMPASS Pathways plc | Award(A) | 75,000 | - | $0 | Direct |
| Mar 11, 2026 | CMPS COMPASS Pathways plc | Tax Payment(F) | 1,781 | $6.89 | $12,271 | Direct |
| Mar 2, 2026 | CMPS COMPASS Pathways plc | Tax Payment(F) | 4,467 | $7.02 | $31,358 | Direct |
| Jun 12, 2025 | PCVX Vaxcyte, Inc. | Award(A) | 3,041 | - | - | Direct |
| Mar 11, 2025 | CMPS COMPASS Pathways plc | Award(A) | 25,000 | - | - | Direct |
| Mar 3, 2025 | CMPS COMPASS Pathways plc | Tax Payment(F) | 4,468 | $3.67 | $16,398 | Direct |
| Jan 15, 2025 | PCVX Vaxcyte, Inc. | Sale(S) | 529 | $88.54 | $46,836 | Direct |
| Jan 15, 2025 | PCVX Vaxcyte, Inc. | Sale(S) | 1,136 | $82.89 | $94,168 | Direct |
| Jan 15, 2025 | PCVX Vaxcyte, Inc. | Sale(S) | 1,202 | $83.93 | $100,885 | Direct |
| Jan 15, 2025 | PCVX Vaxcyte, Inc. | Sale(S) | 1,043 | $85.29 | $88,961 | Direct |
| Jan 15, 2025 | PCVX Vaxcyte, Inc. | Sale(S) | 966 | $86.26 | $83,324 | Direct |
| Jan 15, 2025 | PCVX Vaxcyte, Inc. | Sale(S) | 1,013 | $87.38 | $88,513 | Direct |
| Jan 15, 2025 | PCVX Vaxcyte, Inc. | Exercise(M) | 6,250 | $22.70 | $141,875 | Direct |
| Jan 15, 2025 | PCVX Vaxcyte, Inc. | Sale(S) | 146 | $80.46 | $11,747 | Direct |
| Jan 15, 2025 | PCVX Vaxcyte, Inc. | Sale(S) | 215 | $81.53 | $17,530 | Direct |
| Sep 17, 2024 | PCVX Vaxcyte, Inc. | Sale(S) | 241 | $114.64 | $27,628 | Direct |
| Sep 17, 2024 | PCVX Vaxcyte, Inc. | Sale(S) | 1,445 | $115.32 | $166,634 | Direct |
| Sep 17, 2024 | PCVX Vaxcyte, Inc. | Sale(S) | 4,308 | $116.62 | $502,387 | Direct |
| Sep 17, 2024 | PCVX Vaxcyte, Inc. | Sale(S) | 256 | $117.51 | $30,083 | Direct |
| Sep 17, 2024 | PCVX Vaxcyte, Inc. | Exercise(M) | 6,250 | $22.70 | $141,875 | Direct |
1-21 of 21 transactions
About Loxam Teri
Loxam Teri (SEC CIK 0001829111) files insider reports with the SEC as Director of Vaxcyte, Inc. (PCVX) and Chief Financial Officer of COMPASS Pathways plc (CMPS).
Signal8 holds 9 ownership filings by Loxam Teri, all Form 4s, filed between Sep 18, 2024 and Jun 16, 2026. Those filings report 21 transactions, from Sep 17, 2024 to Jun 15, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Loxam Teri's filings is in SAN CARLOS, CA.
Recent filings by Loxam Teri
- Jun 15, 2026: Grant or award of PCVX shares (Form 4, code A).
- Mar 26, 2026: Grant or award of CMPS shares (Form 4, code A).
- Mar 11, 2026: Tax withholding of CMPS shares (Form 4, code F).
- Mar 2, 2026: Tax withholding of CMPS shares (Form 4, code F).
- Jun 12, 2025: Grant or award of PCVX shares (Form 4, code A).
Other insiders filing for Vaxcyte, Inc. (PCVX)
- Wassil Jim, EVP, Chief Scientific Ofc, COO
- Cowan Elvia, SVP, Finance & CAO
- PICKERING GRANT, CHIEF EXECUTIVE OFFICER
- GUGGENHIME ANDREW, PRESIDENT AND CFO
- Dhaliwal Harpreet S., Chief Technical Ops Officer
- Jodar Luis, Chief Medical Officer